Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial. (linkinghub.elsevier.com)

Authors: Xiong Y … Wang Y Journal: The Lancet Published: 2026-02-21 DOI: https://doi.org/10.1016/S0140-6736(25)02633-9